OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
February 01, 2016
The Biosimilars Forum launched Partnership for Biosimilars Education and Access, an education initiative raising awareness of biosimilars in the US.
The reporter bioassay, used to evaluate ADCC activity of therapeutic antibodies, complements the classical ADCC assay.
January 28, 2016
Hermes Pharma has commercially implemented hot-melt coating (HMC) technology at its production facility.
NICE announces plans to back biosimilar alternatives to Merck’s Remicade.
January 26, 2016
Novartis announced on Jan. 5, 2016 that the company is collaborating with Qualcomm to develop cloud-based technology for COPD patients.
January 13, 2016
The collaboration will focus on development of novel molecules using SMARTag technology to couple different therapeutic modalities.
January 07, 2016
FDA approved 45 novel new drugs in 2015, the highest number of approvals since 1996 and second-highest ever.
January 05, 2016
Ionis Pharmaceuticals receives orphan drug designation for HTTRx for the treatment of Huntington’s disease.
January 04, 2016
BioPharm highlights the monoclonal antibodies that may gain United States regulatory approval in 2016.
January 02, 2016
Parenteral packaging of the future will include more automated lines, ready-to-fill packaging formats, and supply-chain transparency.